Bridge City Capital LLC Has $5.76 Million Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Bridge City Capital LLC lifted its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 7.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 64,947 shares of the company’s stock after purchasing an additional 4,235 shares during the quarter. U.S. Physical Therapy accounts for approximately 1.5% of Bridge City Capital LLC’s holdings, making the stock its 18th biggest holding. Bridge City Capital LLC owned approximately 0.43% of U.S. Physical Therapy worth $5,761,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. CBIZ Investment Advisory Services LLC grew its stake in U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after buying an additional 122 shares during the last quarter. Venturi Wealth Management LLC grew its position in U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock worth $64,000 after acquiring an additional 704 shares during the last quarter. KBC Group NV increased its holdings in U.S. Physical Therapy by 68.6% during the 3rd quarter. KBC Group NV now owns 774 shares of the company’s stock valued at $66,000 after purchasing an additional 315 shares in the last quarter. Pacer Advisors Inc. bought a new position in U.S. Physical Therapy in the 4th quarter valued at $113,000. Finally, First Horizon Advisors Inc. boosted its stake in U.S. Physical Therapy by 25.1% in the third quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock worth $126,000 after purchasing an additional 298 shares in the last quarter.

U.S. Physical Therapy Stock Performance

Shares of USPH opened at $72.52 on Friday. The firm has a market cap of $1.10 billion, a P/E ratio of 77.14, a PEG ratio of 3.54 and a beta of 1.51. U.S. Physical Therapy, Inc. has a twelve month low of $72.27 and a twelve month high of $113.63. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The firm’s 50 day moving average price is $84.85 and its two-hundred day moving average price is $87.00.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The company had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. On average, analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be given a $0.45 dividend. The ex-dividend date is Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.48%. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s payout ratio is currently 97.83%.

Insider Buying and Selling

In other news, COO Graham D. Reeve sold 1,730 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the sale, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. This represents a 19.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 1.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages have weighed in on USPH. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. Barrington Research reduced their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a report on Friday, February 28th. JMP Securities assumed coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price for the company. JPMorgan Chase & Co. decreased their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday. Finally, Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $100.00 to $115.00 in a report on Monday, December 16th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, U.S. Physical Therapy presently has an average rating of “Moderate Buy” and a consensus price target of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.